Vaxcyte, Inc.
PCVX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,905,798 | $4,422,457 | $5,123,692 | $10,056,106 |
| - Cash | $281,080 | $306,744 | $346,850 | $387,878 |
| + Debt | $84,443 | $85,845 | $87,209 | $71,110 |
| Enterprise Value | $4,709,161 | $4,201,558 | $4,864,051 | $9,739,338 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$4,989 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$209,766 | -$161,584 | -$175,919 | -$52,577 |
| % Margin | – | – | – | – |
| Net Income | -$212,830 | -$166,573 | -$140,718 | -$137,080 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.56 | -1.22 | -1.04 | -1.12 |
| % Growth | -27.9% | -17.3% | 7.1% | – |
| Operating Cash Flow | -$143,305 | -$121,166 | -$166,274 | -$111,401 |
| Capital Expenditures | -$12,046 | $19,516 | -$26,751 | -$30,027 |
| Free Cash Flow | -$155,351 | -$101,650 | -$193,025 | -$141,428 |